Back to top
more

Cerner Corporation (CERN)

(Delayed Data from NSDQ)

$68.47 USD

68.47
2,167,881

+0.46 (0.68%)

Updated May 3, 2019 04:00 PM ET

After-Market: $68.46 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

CPSI vs. CERN: Which Stock Is the Better Value Option?

by Zacks Equity Research

CPSI vs. CERN: Which Stock Is the Better Value Option?

Cerner (CERN) Q4 Earnings Meet Estimates, Revenues Miss

by Zacks Equity Research

Cerner (CERN) gains from solid segmental revenues in fourth-quarter 2018. However, the company's 2019 guidance disappoints.

Cerner (CERN) Q4 Earnings Meet Estimates

by Zacks Equity Research

Cerner (CERN) delivered earnings and revenue surprises of 0.00% and -1.99%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

Cerner (CERN) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Cerner (CERN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cerner (CERN) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Cerner's (CERN) fourth-quarter 2018 results are likely to be hurt by year-over-year decline in bookings; Q4 guidance promising.

Stock Market News For Jan 18, 2019

by Zacks Equity Research

Benchmarks ended in the green on Thursday, extending the streak of gains to three days on the trot.

Cerner Picked by Remi Vista for Behavioral Health Technology

by Zacks Equity Research

Apart from Cerner Integrated, Cerner's (CERN) revenue cycle solutions will help Remi Vista's financial operations.

Cerner (CERN) Teams Up With Nebraska-Based LRHC, Shares Up

by Zacks Equity Research

Cerner's (CERN) coveted Millennium platform has seen rising demand in recent times.

Cerner & Christiana Care Unite to Offer Bariatric Services

by Zacks Equity Research

Cerner (CERN) likely to gain from increased obesity rates in the United States.

Stock Market News For Jan 4, 2019

by Zacks Equity Research

Markets crashed on Thursday following Apple???s CEO Tim Cook???s announcement that the tech mega-cap had slashed its revenue guidance for the first quarter.

Here's Why You Should Hold on to Cerner (CERN) Stock for Now

by Zacks Equity Research

A bullish guidance for 2018 and a series of latest developments make Cerner (CERN) a promising investment pick.

Cerner (CERN) Collaborates With McKesson's CoverMyMeds

by Zacks Equity Research

Cerner's (CERN) ePrescribe workflow solution is likely to partner with CoverMyMeds' RxBenefit Clarity solution for prescription price transparency.

Stock Market News For Dec 18, 2018

by Zacks Equity Research

U.S. stocks collapsed for the second straight day as investors remained wary of the Fed's widely expected fourth rate hike for 2018

Cerner's (CERN) Millennium Picked by Mid-Valley Hospital

by Zacks Equity Research

Cerner's (CERN) EHR platforms have seen a series of developments in recent times.

CPSI or CERN: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

CPSI vs. CERN: Which Stock Is the Better Value Option?

Cerner (CERN) Looks Good: Stock Adds 5.1% in Session

by Zacks Equity Research

Cerner (CERN) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Cerner's (CERN) Q3 Earnings Match Estimates, Bookings Up Y/Y

by Zacks Equity Research

Cerner (CERN) gains from strong segmental revenues in the third quarter. Guidance for 2018 is impressive.

Cerner (CERN) Q3 Earnings Match Estimates

by Zacks Equity Research

Cerner (CERN) delivered earnings and revenue surprises of 0.00% and -1.60%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Medical Product Earnings Lineup for Oct 25: SYK, CERN & More

by Zacks Equity Research

Long-term potential of the Medical Products industry looks promising at the moment amid certain short-term geopolitical insecurities.

Cerner (CERN) Q3 Earnings Preview: How Are Events Shaping Up?

by Zacks Equity Research

Cerner (CERN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Veeva Launches Vault SiteDocs for Regulatory Documentation

by Zacks Equity Research

Veeva's (VEEV) Vault SiteDocs Platform conducts high-quality, compliant clinical trials with greater visibility to researchers.

    What's in Store for Cerner (CERN) This Earnings Season?

    by Zacks Equity Research

    Cerner's (CERN) third-quarter 2018 results are likely to be hurt by soft segmental results; guidance promising.

      Varian (VAR) Buys Noona to Boost Oncology Software Services

      by Zacks Equity Research

      Varian's (VAR) latest move provides it significant exposure to the cloud-based oncology services market.

        Cerner's Millennium Platform Integrated at McLaren Hospital

        by Zacks Equity Research

        Cerner's (CERN) Millennium HCIT platform sees a series of developments in 2018.

        Here's Why You Should Hold on to athenahealth (ATHN) for Now

        by Zacks Equity Research

        athenahealth (ATHN) likely to gain from focus on cloud-based healthcare services.